Carla Bauer
Director, Oncology Search & Evaluation, Business Development & Licensing Merck & Co
Carla Bauer is Director, Oncology Search & Evaluation in Business Development & Licensing at Merck. She transitioned from a bench-science leadership background into BD&L, and prior to Merck held multiple roles at Novartis spanning alliance management, strategic transactions, and oncology search & evaluation.
Seminars
Wednesday 9th September 2026
Pharma Icebreaker Panel Discussion: Targeted Oncology Biologics
8:00 am
- Understanding what it takes for pharma to invest. What are the current budgetary considerations within pharma?
- How is pharma assessing novel technologies, and where do they place within portfolios?
- What feels differentiated in a crowded space? From pharma’s perspective, what will make something best-in-class?
